ID

39979

Descrizione

MK-0954E Phase III Long-Term Study in Participants With Hypertension (MK-0954E-356); ODM derived from: https://clinicaltrials.gov/show/NCT01299376

collegamento

https://clinicaltrials.gov/show/NCT01299376

Keywords

versioni (1)
  1. 07/03/20 07/03/20 -
Titolare del copyright

See clinicaltrials.gov

Caricato su

7 marzo 2020

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Hypertension NCT01299376

Inglese

Eligibility Hypertension NCT01299376

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
participant has a diagnosis of essential hypertension.
Descrizione

Essential Hypertension

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0085580
participant is being treated with a single, or dual combination treatment for hypertension and will be able to discontinue the prior antihypertensive medication.
Descrizione

Antihypertensive therapy | Combined Modality Therapy Dual Hypertensive disease | Ability Discontinue Antihypertensive Agents

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0585941
UMLS CUI [2,1]
C0009429
UMLS CUI [2,2]
C0205173
UMLS CUI [2,3]
C0020538
UMLS CUI [3,1]
C0085732
UMLS CUI [3,2]
C1444662
UMLS CUI [3,3]
C0003364
participant has a mean trough sidbp of ≥ 90 mmhg and < 110 mmhg.
Descrizione

Sitting diastolic blood pressure mean

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1319894
UMLS CUI [1,2]
C0444504
participant has a mean trough sisbp of ≥ 140 mmhg and < 200 mmhg.
Descrizione

Sitting systolic blood pressure mean

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1319893
UMLS CUI [1,2]
C0444504
participant has no clinically significant abnormality at screening visit.
Descrizione

Abnormality Clinical Significance Absent

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1704258
UMLS CUI [1,2]
C2826293
UMLS CUI [1,3]
C0332197
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
participant is currently taking >2 antihypertensive medications.
Descrizione

Antihypertensive Agents Quantity

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0003364
UMLS CUI [1,2]
C1265611
participant has a history of significant multiple and/or severe allergies to ingredients of nu-lotan or preminent, amlodipine or dihydropyridine drug, and thiazide drug or related drug (i.e., sulfonamide-containing "chlortalidone" medicines).
Descrizione

Multiple allergies Ingredient Losartan Potassium | Severe allergy Ingredient Losartan Potassium | Multiple allergies Ingredient Preminent | Severe allergy Ingredient Preminent | Multiple allergies Ingredient Amlodipine | Severe allergy Ingredient Amlodipine | Multiple allergies Ingredient Dihydropyridine | Severe allergy Ingredient Dihydropyridine | Multiple allergies Ingredient Thiazide | Severe allergy Ingredient Thiazide | Multiple allergies Ingredient Chlorthalidone | Severe allergy Ingredient Chlorthalidone

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0740281
UMLS CUI [1,2]
C1550600
UMLS CUI [1,3]
C0700492
UMLS CUI [2,1]
C2945656
UMLS CUI [2,2]
C1550600
UMLS CUI [2,3]
C0700492
UMLS CUI [3,1]
C0740281
UMLS CUI [3,2]
C1550600
UMLS CUI [3,3]
C0138304
UMLS CUI [4,1]
C2945656
UMLS CUI [4,2]
C1550600
UMLS CUI [4,3]
C0138304
UMLS CUI [5,1]
C0740281
UMLS CUI [5,2]
C1550600
UMLS CUI [5,3]
C0051696
UMLS CUI [6,1]
C2945656
UMLS CUI [6,2]
C1550600
UMLS CUI [6,3]
C0051696
UMLS CUI [7,1]
C0740281
UMLS CUI [7,2]
C1550600
UMLS CUI [7,3]
C0220821
UMLS CUI [8,1]
C2945656
UMLS CUI [8,2]
C1550600
UMLS CUI [8,3]
C0220821
UMLS CUI [9,1]
C0740281
UMLS CUI [9,2]
C1550600
UMLS CUI [9,3]
C0541746
UMLS CUI [10,1]
C2945656
UMLS CUI [10,2]
C1550600
UMLS CUI [10,3]
C0541746
UMLS CUI [11,1]
C0740281
UMLS CUI [11,2]
C1550600
UMLS CUI [11,3]
C0008294
UMLS CUI [12,1]
C2945656
UMLS CUI [12,2]
C1550600
UMLS CUI [12,3]
C0008294
participant is, at the time of signing informed consent, a user of recreational or illicit drugs or has had a recent history within the last year of drug or alcohol abuse or dependence.
Descrizione

Recreational drug use | Illicit medication use | Substance Use Disorders

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0013146
UMLS CUI [2]
C0281875
UMLS CUI [3]
C0038586
participant is pregnant or breastfeeding, or expecting to conceive or the pregnancy test is positive at screening visit (visit 1).
Descrizione

Pregnancy | Breast Feeding | Pregnancy, Planned | Pregnancy test positive

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3]
C0032992
UMLS CUI [4]
C0240802
participant is currently participating or has participated in a study with an investigational compound or device within 30 days of signing informed consent.
Descrizione

Study Subject Participation Status | Investigational New Drugs | Investigational Medical Device

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0013230
UMLS CUI [3]
C2346570
Ritorna all'inizio della pagina

Similar models

Eligibility Hypertension NCT01299376

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Essential Hypertension
Item
participant has a diagnosis of essential hypertension.
boolean
C0085580 (UMLS CUI [1])
Antihypertensive therapy | Combined Modality Therapy Dual Hypertensive disease | Ability Discontinue Antihypertensive Agents
Item
participant is being treated with a single, or dual combination treatment for hypertension and will be able to discontinue the prior antihypertensive medication.
boolean
C0585941 (UMLS CUI [1])
C0009429 (UMLS CUI [2,1])
C0205173 (UMLS CUI [2,2])
C0020538 (UMLS CUI [2,3])
C0085732 (UMLS CUI [3,1])
C1444662 (UMLS CUI [3,2])
C0003364 (UMLS CUI [3,3])
Sitting diastolic blood pressure mean
Item
participant has a mean trough sidbp of ≥ 90 mmhg and < 110 mmhg.
boolean
C1319894 (UMLS CUI [1,1])
C0444504 (UMLS CUI [1,2])
Sitting systolic blood pressure mean
Item
participant has a mean trough sisbp of ≥ 140 mmhg and < 200 mmhg.
boolean
C1319893 (UMLS CUI [1,1])
C0444504 (UMLS CUI [1,2])
Abnormality Clinical Significance Absent
Item
participant has no clinically significant abnormality at screening visit.
boolean
C1704258 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Antihypertensive Agents Quantity
Item
participant is currently taking >2 antihypertensive medications.
boolean
C0003364 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
Multiple allergies Ingredient Losartan Potassium | Severe allergy Ingredient Losartan Potassium | Multiple allergies Ingredient Preminent | Severe allergy Ingredient Preminent | Multiple allergies Ingredient Amlodipine | Severe allergy Ingredient Amlodipine | Multiple allergies Ingredient Dihydropyridine | Severe allergy Ingredient Dihydropyridine | Multiple allergies Ingredient Thiazide | Severe allergy Ingredient Thiazide | Multiple allergies Ingredient Chlorthalidone | Severe allergy Ingredient Chlorthalidone
Item
participant has a history of significant multiple and/or severe allergies to ingredients of nu-lotan or preminent, amlodipine or dihydropyridine drug, and thiazide drug or related drug (i.e., sulfonamide-containing "chlortalidone" medicines).
boolean
C0740281 (UMLS CUI [1,1])
C1550600 (UMLS CUI [1,2])
C0700492 (UMLS CUI [1,3])
C2945656 (UMLS CUI [2,1])
C1550600 (UMLS CUI [2,2])
C0700492 (UMLS CUI [2,3])
C0740281 (UMLS CUI [3,1])
C1550600 (UMLS CUI [3,2])
C0138304 (UMLS CUI [3,3])
C2945656 (UMLS CUI [4,1])
C1550600 (UMLS CUI [4,2])
C0138304 (UMLS CUI [4,3])
C0740281 (UMLS CUI [5,1])
C1550600 (UMLS CUI [5,2])
C0051696 (UMLS CUI [5,3])
C2945656 (UMLS CUI [6,1])
C1550600 (UMLS CUI [6,2])
C0051696 (UMLS CUI [6,3])
C0740281 (UMLS CUI [7,1])
C1550600 (UMLS CUI [7,2])
C0220821 (UMLS CUI [7,3])
C2945656 (UMLS CUI [8,1])
C1550600 (UMLS CUI [8,2])
C0220821 (UMLS CUI [8,3])
C0740281 (UMLS CUI [9,1])
C1550600 (UMLS CUI [9,2])
C0541746 (UMLS CUI [9,3])
C2945656 (UMLS CUI [10,1])
C1550600 (UMLS CUI [10,2])
C0541746 (UMLS CUI [10,3])
C0740281 (UMLS CUI [11,1])
C1550600 (UMLS CUI [11,2])
C0008294 (UMLS CUI [11,3])
C2945656 (UMLS CUI [12,1])
C1550600 (UMLS CUI [12,2])
C0008294 (UMLS CUI [12,3])
Recreational drug use | Illicit medication use | Substance Use Disorders
Item
participant is, at the time of signing informed consent, a user of recreational or illicit drugs or has had a recent history within the last year of drug or alcohol abuse or dependence.
boolean
C0013146 (UMLS CUI [1])
C0281875 (UMLS CUI [2])
C0038586 (UMLS CUI [3])
Pregnancy | Breast Feeding | Pregnancy, Planned | Pregnancy test positive
Item
participant is pregnant or breastfeeding, or expecting to conceive or the pregnancy test is positive at screening visit (visit 1).
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0032992 (UMLS CUI [3])
C0240802 (UMLS CUI [4])
Study Subject Participation Status | Investigational New Drugs | Investigational Medical Device
Item
participant is currently participating or has participated in a study with an investigational compound or device within 30 days of signing informed consent.
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
C2346570 (UMLS CUI [3])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial